Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
Pharmacology, Toxicology and Pharmaceutical Science
2
5%
Chemical Engineering
1
3%
Nursing and Health Professions
1
3%
Other
1
3%
Unknown
24
62%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 January 2022.
All research outputs
#2,747,253
of 28,863,574 outputs
Outputs from Open Forum Infectious Diseases
#1,227
of 5,585 outputs
Outputs of similar age
#57,993
of 455,905 outputs
Outputs of similar age from Open Forum Infectious Diseases
#57
of 141 outputs
Altmetric has tracked 28,863,574 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,585 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.0. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,905 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
